Correlation Between Global Dividend and Big Pharma
Can any of the company-specific risk be diversified away by investing in both Global Dividend and Big Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Global Dividend and Big Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Global Dividend Growth and Big Pharma Split, you can compare the effects of market volatilities on Global Dividend and Big Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Global Dividend with a short position of Big Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Global Dividend and Big Pharma.
Diversification Opportunities for Global Dividend and Big Pharma
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Global and Big is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Global Dividend Growth and Big Pharma Split in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Big Pharma Split and Global Dividend is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Global Dividend Growth are associated (or correlated) with Big Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Big Pharma Split has no effect on the direction of Global Dividend i.e., Global Dividend and Big Pharma go up and down completely randomly.
Pair Corralation between Global Dividend and Big Pharma
Assuming the 90 days trading horizon Global Dividend Growth is expected to under-perform the Big Pharma. In addition to that, Global Dividend is 1.46 times more volatile than Big Pharma Split. It trades about -0.05 of its total potential returns per unit of risk. Big Pharma Split is currently generating about -0.03 per unit of volatility. If you would invest 1,325 in Big Pharma Split on October 24, 2024 and sell it today you would lose (10.00) from holding Big Pharma Split or give up 0.75% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Global Dividend Growth vs. Big Pharma Split
Performance |
| Timeline |
| Global Dividend Growth |
| Big Pharma Split |
Global Dividend and Big Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Global Dividend and Big Pharma
The main advantage of trading using opposite Global Dividend and Big Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Global Dividend position performs unexpectedly, Big Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Big Pharma will offset losses from the drop in Big Pharma's long position.| Global Dividend vs. E Split Corp | Global Dividend vs. Brompton Split Banc | Global Dividend vs. Life Banc Split | Global Dividend vs. Real Estate E Commerce |
| Big Pharma vs. Sustainable Power Infrastructure | Big Pharma vs. Global Dividend Growth | Big Pharma vs. Brompton Lifeco Split | Big Pharma vs. Prime Dividend Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |